Provided by Tiger Fintech (Singapore) Pte. Ltd.

MetaVia Inc

0.7514
+0.05217.45%
Post-market: 0.7488-0.0026-0.35%17:47 EST
Volume:266.83K
Turnover:195.16K
Market Cap:18.19M
PE:-0.73
High:0.7588
Open:0.7200
Low:0.6869
Close:0.6993
52wk High:2.75
52wk Low:0.5555
Shares:24.21M
Float Shares:9.22M
Volume Ratio:0.34
T/O Rate:2.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0331
EPS(LYR):-3.5570
ROE:-168.18%
ROA:-58.41%
PB:2.87
PE(LYR):-0.21

Loading ...

Company Profile

Company Name:
MetaVia Inc
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
9
Office Location:
545 Concord Avenue,Suite 210,Cambridge,Massachusetts,United States
Zip Code:
02138
Fax:
- -
Introduction:
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy for both NASH and T2D; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP1R/GCGR dual agonist for the treatment of NASH and obesity. The company also develops ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene for various indications, including COVID-19 in combination with ANA001. NeuroBo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.

Directors

Name
Position
Andrew Koven
Chairman of the Board
Hyung Heon Kim
Director and Chief Executive Officer, President, Principal Financial Officer and Principal Accounting Officer
D. Gordon Strickland
Director
Jason L. Groves
Director
Mark A. Glickman
Director
Michael Salsbury
Director
Na Yeon Kim
Director

Shareholders

Name
Position
Hyung Heon Kim
Director and Chief Executive Officer, President, Principal Financial Officer and Principal Accounting Officer